Skip to main content
Home
Research + Clinical Trials
Find a Clinical Trial
Search
Participant Age
Apply
Filter
Conditions treated
Chronic kidney disease
Department
Division of Nephrology
Medicine
Gender
All genders
Services
Allergy
Amyloidosis
Bladder Cancer
Blood Disorders + Hematology
Brain Tumor
Breast Cancer
Cancer
Cancer + Hematology (Pediatrics)
Cardiovascular
Colon + Rectal Cancer
Critical Care
Dentistry
Gastroenterology + Digestive Health
Gastroenterology + Digestive Health (Pediatrics)
Gynecologic Cancer
Head + Neck Cancer
Hematologic Cancers
Infectious Diseases
Inflammatory Bowel Disease (IBD)
Liver Disease
Lung Cancer
Mycobacterial Disease
Myeloma + AL Amyloidosis
Nephrology
Nephrology (Pediatrics)
Osteoarthritis
Pancreatic Cancer
Pulmonary Hypertension
Pulmonology
Radiation Oncology
Rheumatoid Arthritis
Rheumatology
Thoracic Surgery
Urology
Kidney Function Evaluation
Showing 1 - 1 out of 1
Medicine
Kidney Function Evaluation
Reset search
MLS-101-206
A PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LORUNDROSTAT ALONE, AND LORUNDOSTAT IN COMBINATION WITH DAPAGLIFLOZIN, IN ADULTS WITH HYPERTENSION AND CHRONIC KIDNEY DISEASE WITH ALBUMINURIA
Chronic kidney disease
All genders
18-100
Recruiting now
Department of Medicine, Division of Nephrology
Learn more
Jump back to top